The objective of this observational study is to assess the efficacy of two neuropsychological tests (MoCA-B and MoCA-Blind) in detecting cognitive decline in older adults. The main questions it aims to answer are:
Can the results obtained by older adults on the MoCA-B distinguish between those with and without cognitive decline? Can the results obtained by older adults on the MoCA-Blind distinguish between those with and without cognitive decline?
Participants will be required to: 1. Complete a sociodemographic questionnaire; 2. Undergo a visual acuity test; 3. Complete the Pfeffer and IQCODE scales; and 4. Complete the MMSE, MoCA-B, and MoCA-Blind.
* Older adults aged 60 and over;
Participants under 60 years of age
Participants with a prior neuropsychological, neurological, or psychiatric diagnosis that could negatively influence assessment results, such as schizophrenia, stroke within the last three months, intellectual disability, etc
Participants with self-reported or diagnosed hearing impairment (hearing loss or deafness) that is not corrected by hearing aids.
Older adults (60 years or older) with and without cognitive decline and with and without visual impairment.
Case-control
Cross-sectional
Not listed
Optimal cut-off score for the MoCA-B and MoCA-Blind
The scores obtained by the participants (0 to 30) will be used to calculate the ROC curve and determine the optimal cutoff point (highest sensitivity and specificity) to distinguish between cognitive decline and healthy individuals.
Click on the lead sponsor to view all of their trials.
Universidade Federal do Rio Grande do Norte
Lead sponsor
Federal University of São Paulo
Collaborator
Universidade Federal de Goias
Collaborator
Universidade Estadual de Goiás
Collaborator
Universidade Federal do Rio Grande (FURG)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
